Novo Nordisk/Eli Lilly ' s Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has determined that there is no substantial evidence supporting a link between Glucagon-Like Peptide-1 receptor agonists (GLP-1) and suicidal or self-injurious thoughts and behaviors. The assessment comes following…#glp1 #fda #obese #saxenda #xultophy #sanofisas #snylyxumia #suliqua #elilillyand #cosllytrulicity
Source: Reuters: Health - Category: Consumer Health News Source Type: news